期刊文献+

维生素D防治慢性胃炎小鼠幽门螺杆菌感染的研究 被引量:3

Prevention and treatment and its mechanism on Helicobacter pylori infection in mice with chronic gastritis by vitamin D
原文传递
导出
摘要 目的探讨维生素D在幽门螺杆菌感染小鼠体内防治幽门螺杆菌作用及其作用机制。方法野生型C57BL/6J小鼠随机分为4个实验组和2个对照组,每组各6只。实验组ig幽门螺杆菌浓度至少5×10~8 CFU/mL磷酸盐缓冲液建立慢性胃炎模型,分别ig维生素D 0.003、0.012、0.048μg/d(1、4、16倍剂量),处理12周。处死小鼠,留取胃组织进行组织病理学、免疫组织化学和RT-PCR检测p53、NF-κB p65基因表达。结果 0.012、0.048μg/d维生素D能减少小鼠幽门螺杆菌定植、炎症细胞浸润和炎症反应,能增加p53基因表达,降低了NF-κB p65基因表达(P<0.05),并呈剂量相关性,但在0.012、0.048μg/d组间差异无统计学意义。结论大剂量维生素D可以促进p53表达,降低NF-κB p65表达,具有防治幽门螺杆菌感染,减轻幽门螺杆菌感染相关炎症反应的作用。 Objective To discuss prevention and treatment of vitamin D on Helicobacter pylori in mice in vivo, and explore its mechanism. Methods Wild type C57 BL/6 J mice were randomly divided into 4 experiment groups and 2 control groups, and each group had 6 mice. Mice were ig administration with H. pylori above 5×10~8 CFU/mL phosphate buffer solution to establish chronic gastritis model. Mice in experiment groups were ig administration with 0.003, 0.012, and 0.048 μg/d(1, 4, and 16 times dose) for 12 weeks. The mice were sacrificed, and gastric tissues were collected. Histopathological and immunohistochemical results were observed, and expressions of p53 and NF-κB p65 were determined by RT-PCR method. Results Vitamin D(0.012 and 0.048 μg/d) could reduce the colonization of H. pylori, inflammatory cell infiltration, and inflammatory reaction, increase the expression of p53 gene, and decrease the expression of NF-κB p65 gene in a dose dependent manner in mice(P〈0.05), but there was no significant difference between two groups. Conclusion The high dose of vitamin D treated has anti Helicobacter pylori in mice. High dose of vitamin D can promote the expression of p53 and reduce the expression of NF-κB p65. It can prevent and treat H. pylori infection and alleviate the inflammation related to H. pylori infection.
作者 刘毅毅 李蕾 吉秀芹 温风霞 尹燕楠 焦建新 LIU Yi-yi;LI Lei;JI Xiu-qin;WEN Feng-xia;YIN Yan-nan;JIAO Jian-xin(Weifang Medical University,Weifang 261042,China;Department of Gastroenterology,the Affiliated Hospital of Weifang Medical University,Weifang 261031,China)
出处 《现代药物与临床》 CAS 2018年第11期2781-2786,共6页 Drugs & Clinic
关键词 维生素D 幽门螺杆菌 NF-ΚB P65 P53 Vitamin D Helicobacterpylori NF-κB p65 p53
  • 相关文献

参考文献3

二级参考文献25

  • 1宁磊,王保宁,赵雅静,陈翠萍,刘德培.幽门螺杆菌致人胃病的小鼠模型研究[J].中国实验动物学报,2000,8(4):193-197. 被引量:2
  • 2Francis R, Aspray T, Fraser W, et al. http://www, nos. org. uk/document, doc? id = 1352. Published 2013.
  • 3Institute of Medicine. 2011 Dietary reference intakes for calcium and vitamin D. Washington, DC: The National Academies Press. 2011.
  • 4Nowson CA, McGrath JJ, Ebeling PR, et al. Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust,2012,196( 11 ) : 686-687.
  • 5Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism, 2011,96 (7) : 1911-1930.
  • 6Hanley DA, Cranney A, Jones G, et al, Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. Canadian Medical Association Journal,2010,182(12) : E610-E618.
  • 7Dawson-Hughes B, Mithal A, Bonjour JP, et al. IOF position statement : vitamin D recommendations for older adults. Osteoporos Int, 2010,21 (7) : 1151-1154.
  • 8National Osteoporosis Foundation. (2014) NOF' s Clinician' s Guide to Prevention and Treatment of Osteoporosis ( 2013 ). Washington, DC. 2014.
  • 9National Institutes of Health. http://ods, od. nih. gov/factsheets/ VitaminD-HealthProfessional/. Published 2011.
  • 10Hathcock JN, Shao A, Vieth R, et al. Risk assessment for vitamin D. Am J Clin Nutr, 2007,85( 1 ) : 6-18.

共引文献55

同被引文献42

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部